WilliamWerbelMDPhD

HIV/AIDS Medicine, Transplant/Immunocompromised States, Microbiology

Physician

Dr. Werbel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
4940 Eastern Avenue
Baltimore, MD 21224
Phone+1 410-550-9080

Fax+1 410-550-1169

University of Michigan Medical SchoolClass of 2013
McGaw Medical Center of Northwestern UniversityChief Residency, Internal Medicine

PubMed

A third COVID-19 vaccine dose in kidney transplant recipients induces antibody response to vaccine and Omicron variants but shows limited Ig subclass switching.
Jenny M Lee, Jaiprasath Sachithanandham, John S Lee, Janna R Shapiro, Maggie Li
Microbiology Spectrum. 2025-03-04
Impact of Bebtelovimab Treatment Timing on COVID-19 Outcomes in Ambulatory Solid Organ Transplant Recipients.
Sonsoles Salto-Alejandre, Willa Cochran, Zishan Siddiqui, Julie Langlee, Lauren Boyer
Transplant Infectious Disease. 2024-11-16
3 citations
Prevalence and Risk Factors of Postacute Sequelae of COVID-19 in Adults With Systemic Autoimmune Rheumatic Diseases.
Mayan S Teles, Janetta Brundage, Teresa Po-Yu Chiang, Jennifer L Alejo, Nicolas Henriquez
The Journal of Rheumatology. 2024-09-01

Study: RSV Vaccine May Be More Effective at Protecting Healthier Older AdultsJanuary 2nd, 2025
Seniors on Immunosuppressant Show Weaker Vaccine ResponsesDecember 31st, 2024
HMN 2024: How Immunocompromised May Not Produce Enough Protective Antibodies Against RSV After VaccinationDecember 31st, 2024
Join now to see all

The Landscape of Serious Infections following Kidney Transplantation in People Living with HIVJOHNS HOPKINS UNIVERSITY2021–2026